JPH07100185A - Container for medical liquid - Google Patents
Container for medical liquidInfo
- Publication number
- JPH07100185A JPH07100185A JP5250584A JP25058493A JPH07100185A JP H07100185 A JPH07100185 A JP H07100185A JP 5250584 A JP5250584 A JP 5250584A JP 25058493 A JP25058493 A JP 25058493A JP H07100185 A JPH07100185 A JP H07100185A
- Authority
- JP
- Japan
- Prior art keywords
- film
- container
- layer
- medical liquid
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title abstract description 22
- 230000004888 barrier function Effects 0.000 claims abstract description 24
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 claims abstract description 12
- 229920003023 plastic Polymers 0.000 claims abstract description 5
- 239000004033 plastic Substances 0.000 claims abstract description 5
- 239000000919 ceramic Substances 0.000 claims description 9
- 239000007789 gas Substances 0.000 abstract description 17
- 230000035699 permeability Effects 0.000 abstract description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 238000007789 sealing Methods 0.000 abstract description 4
- 238000009736 wetting Methods 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 16
- 239000005022 packaging material Substances 0.000 description 12
- -1 polypropylene Polymers 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000463 material Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920001684 low density polyethylene Polymers 0.000 description 4
- 239000004702 low-density polyethylene Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000007740 vapor deposition Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920002292 Nylon 6 Polymers 0.000 description 2
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 2
- 238000005524 ceramic coating Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000003186 pharmaceutical solution Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000005033 polyvinylidene chloride Substances 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 1
- GVNWZKBFMFUVNX-UHFFFAOYSA-N Adipamide Chemical compound NC(=O)CCCCC(N)=O GVNWZKBFMFUVNX-UHFFFAOYSA-N 0.000 description 1
- 101100160821 Bacillus subtilis (strain 168) yxdJ gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- PGIBJVOPLXHHGS-UHFFFAOYSA-N Di-n-decyl phthalate Chemical compound CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCC PGIBJVOPLXHHGS-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CQBLUJRVOKGWCF-UHFFFAOYSA-N [O].[AlH3] Chemical compound [O].[AlH3] CQBLUJRVOKGWCF-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007733 ion plating Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 125000005487 naphthalate group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920006284 nylon film Polymers 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- GWVUTNGDMGTPFE-UHFFFAOYSA-N trihexyl 2-butanoyloxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCOC(=O)CC(C(=O)OCCCCCC)(OC(=O)CCC)CC(=O)OCCCCCC GWVUTNGDMGTPFE-UHFFFAOYSA-N 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Landscapes
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Laminated Bodies (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は収容医薬液の酸素、炭酸
ガスなどによる変質を防止し、かつ水蒸気の透過性が適
度に調節された医薬液入り容器に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a container containing a medical liquid in which the contained medical liquid is prevented from being deteriorated by oxygen, carbon dioxide gas and the like and the water vapor permeability is appropriately adjusted.
【0002】[0002]
【従来の技術】輸液、血液保存液やその他の医薬液の中
には例えばアミノ酸製剤の如く空気によって変質するも
のがあるが、医薬液を収容、保存する容器の材質として
は軽量性、耐衝撃性、取り扱いの容易さなどの点から軟
質ポリ塩化ビニル、ポリエチレンおよびエチレン酢酸ビ
ニルコポリマーをはじめとする、柔軟性や透明性に優れ
た軟質プラスチックが望まれる場合が多く、これらのポ
リマーはガス、特に酸素に対するバリアー性が十分でな
いので何らかの対策が必要である。2. Description of the Related Art Some infusions, blood preservatives and other medicinal liquids are altered by air, such as amino acid preparations, but the material for the container for storing and storing the medicinal liquid is light weight and shock resistance. In terms of properties, ease of handling, etc., soft polyvinyl chloride, polyethylene and ethylene vinyl acetate copolymer and other flexible plastics with excellent flexibility and transparency are often desired. Some measures are necessary because the barrier property against oxygen is not sufficient.
【0003】従来から行われあるいは試みられている対
策として最も一般的なものは医薬液収容器をさらにガス
バリアー性を持つ外包材で包む方法であり、外包材とし
て(イ)アルミ箔、(ロ)ポリ塩化ビニリデン、(ハ)
エチレンビニルアルコールコポリマー、(ニ)セラミッ
クコートフィルムなどのバリアー材を層として含有する
多層フィルム(またはシート)が用いられている。これ
らのバリアー材の長所あるいは短所は周知の如く次に示
す通りである (イ)アルミ箔:酸素、炭酸ガス、水蒸気などほとんど
の対して大きなバリアー性を示す。不透明であり内容物
が見えない、焼却が出来ない問題がある。The most common countermeasure that has been or has been attempted in the past is to wrap the liquid medicine container with an outer wrapping material having a gas barrier property. As the outer wrapping material, (a) aluminum foil, (b) ) Polyvinylidene chloride, (C)
A multilayer film (or sheet) containing a barrier material such as an ethylene vinyl alcohol copolymer and (d) a ceramic coat film as a layer is used. As is well known, the advantages and disadvantages of these barrier materials are as follows: (a) Aluminum foil: A large barrier property against most of oxygen, carbon dioxide, water vapor and the like. There are problems that it is opaque and the contents cannot be seen, and it cannot be incinerated.
【0004】(ロ)ポリ塩化ビニリデン:室温領域では
ほとんどのガスに対してバリアー性を示し、透明性も良
好であるが、塩素を含むため廃棄処理時に問題を残して
いる。 (ハ)エチレンビニルアルコールコポリマー:
室温領域では酸素や炭酸ガスに対してバリアー性良好で
ある。吸湿性のため水分に対して敏感で高湿度雰囲気で
はバリアー製に劣る。透明性が良く、廃棄処理の問題も
少ない。(B) Polyvinylidene chloride: It has a barrier property against most gases at room temperature and has good transparency, but since it contains chlorine, it has a problem in disposal. (C) Ethylene vinyl alcohol copolymer:
It has a good barrier property against oxygen and carbon dioxide in the room temperature range. Since it is hygroscopic, it is sensitive to moisture and is inferior to a barrier product in a high humidity atmosphere. It has good transparency and there are few disposal problems.
【0005】(ニ)セラミックコートフィルム:アルミ
箔に次ぐバリアー性を示し、温度依存性も(ロ)や
(ハ)に比べ小さく透明性は良好である。またコート層
を薄くできるので灰分は少量であり、廃棄処理の問題は
少ない。(D) Ceramic coat film: Shows barrier properties second only to aluminum foil, has a smaller temperature dependency than (b) and (c), and has good transparency. Also, since the coat layer can be made thin, the amount of ash is small, and there are few problems in disposal.
【0006】従って(ニ)が最も優れた包材と言えるが
医薬液収容容器用の外包材としては不満が残る。すなわ
ち水蒸気バリアー性が大きいため、医薬液収容容器から
蒸散する水分が該容器表面や外包材の間に滞留し、水滴
となる水濡れや曇り現象が生ずることが多いからであり
商品としての価値を著しく低下させるからである。Therefore, although (d) can be said to be the most excellent packaging material, it remains unsatisfactory as an outer packaging material for a drug solution container. That is, since the water vapor barrier property is large, the water evaporated from the liquid medicine container often stays between the surface of the container and the outer packaging material to cause water wetting and clouding as water droplets, which is a value as a product. This is because it is significantly reduced.
【0007】[0007]
【発明が解決しようとする課題】本発明は上記状況に鑑
み、収容医薬液の変質防止用包材における上述の如き諸
問題を解決すべくなされたものである。SUMMARY OF THE INVENTION In view of the above situation, the present invention has been made to solve the above-mentioned problems in the packaging material for preventing the deterioration of the contained medical liquid.
【0008】[0008]
【課題を解決するための手段】本発明者らは前述のセラ
ミックコートフィルムの適用について検討を進めた結
果、前述の「水滴」の問題はエチレンビニルアルコール
コポリマー層含有包材との併用により解決されるのを知
り、医薬液を収容する密封された軟質プラスチック容器
(A)および(B)を内包する密封されたフィルムまた
はシートからなる容器であって(B)がガスバリアー性
セラミックコートフィルムを層として含む多層フィルム
(C)の部分とエチレンビニルアルコールコポリマーフ
ィルムを層として含む多層フィルム(D)の部分とで構
成されていることを特徴とする医薬液入り容器を趣旨と
する本発明に至った。本発明の医薬液入り容器では優れ
た酸素・炭酸ガスバリアー性と適度の水蒸気透過性を持
つため、内容医薬液の変質防止と水濡れ・曇り防止が達
成され、透明で廃棄時の問題が少ないことも長所であ
る。DISCLOSURE OF THE INVENTION The inventors of the present invention have studied the application of the above-mentioned ceramic coat film, and as a result, the above-mentioned problem of "water droplets" has been solved by the combined use with an ethylene vinyl alcohol copolymer layer-containing packaging material. A container comprising a sealed film or sheet containing a sealed soft plastic container (A) and (B) for containing a medicinal solution, wherein (B) is a gas barrier ceramic coated film. The present invention is intended for a container containing a medicinal solution, which is characterized in that it is composed of a multi-layer film (C) part containing as a layer and a multi-layer film (D) part containing an ethylene vinyl alcohol copolymer film as a layer. . The container containing the liquid medicine of the present invention has excellent oxygen / carbon dioxide gas barrier property and appropriate water vapor permeability, so that the deterioration of the liquid medicine and the prevention of water wetting / fogging can be achieved, and it is transparent and has few problems at the time of disposal. That is also an advantage.
【0009】本発明において内包材(医薬液と直接接触
する材料)として用いられる軟質プラスチック容器
(A)は通常公知の軟質ポリマーからなるものであり、
ジ(2−エチルヘキシル)フタレート、ジ−n−デシル
フタレート、ブチリルトリ−n−ヘキシルシトレートな
どを可塑剤とするポリ塩化ビニル(但しこの素材は本発
明の趣旨から鑑みると出来るだけ避けるほうが好まし
い。)、高圧法低密度ポチエチレン、線状低密度ポチエ
チレン、エチレン酢酸ビニルコポリマー、ポリプロピレ
ンなどのポリマーから形成されている。In the present invention, the soft plastic container (A) used as the encapsulating material (the material which comes into direct contact with the medicinal liquid) is made of a commonly known soft polymer,
Polyvinyl chloride having a plasticizer such as di (2-ethylhexyl) phthalate, di-n-decyl phthalate, butyryl tri-n-hexyl citrate (however, it is preferable to avoid this material as much as possible from the point of view of the present invention). , High pressure low density polyethylene, linear low density polyethylene, ethylene vinyl acetate copolymer, polypropylene and other polymers.
【0010】次に外包材のフィルムまたはシート(B)
について説明する。Next, the film or sheet (B) of the outer packaging material
Will be described.
【0011】本発明におけるガスバリアー性セラミック
コートフィルムはポリエチレンテレフタレート、ポリブ
チレンテレフタレート、ポリ−1,4−シクロヘキシレ
ンジメチレンテレフタレート、ポリエチレン−2,6−
ナフタレート、ナイロン−6、ナイロン−66、ポリメ
タキシリレンアジパミド、ポリカーボネート、ポリビニ
ルアルコール、ポリ−4−メチルペンテン−1などおよ
びこれらを主成分とするポリマーからなる比較的耐熱性
・寸法安定性のあるフィルムの片面または両面に酸化ケ
イ素やアルミナ(酸素アルミニウム)の如きセラミック
層を真空蒸着法、イオンプレーティング法、スパッタリ
ング法、ゾル−ゲル法、化学蒸着法などの公知技術で形
成されたガスバリアーフィルムを意味し、加工性、透明
性、ガスバリアー性などのバランスの点でシリカ蒸着ポ
リエチレンテレフタレートフィルムが代表例である。セ
ラミック層の厚さは要求されるガスバリアー性やポリマ
ーフィルムの種類によって異なるが一般的には片面あた
り0.001〜1.0μm、より好ましくは0.005
〜0.8μmが適当である。The gas barrier ceramic coating film in the present invention is polyethylene terephthalate, polybutylene terephthalate, poly-1,4-cyclohexylene dimethylene terephthalate, polyethylene-2,6-.
Naphthalate, nylon-6, nylon-66, polymeta-xylylene adipamide, polycarbonate, polyvinyl alcohol, poly-4-methylpentene-1, etc., and relatively heat-resistant and dimensional-stable polymers composed of these A gas barrier formed by a known technique such as a vacuum vapor deposition method, an ion plating method, a sputtering method, a sol-gel method, or a chemical vapor deposition method, on one or both sides of a film, a ceramic layer such as silicon oxide or alumina (oxygen aluminum). It means a film, and a silica vapor-deposited polyethylene terephthalate film is a typical example in terms of balance of processability, transparency, gas barrier property and the like. The thickness of the ceramic layer varies depending on the required gas barrier property and the type of polymer film, but generally 0.001 to 1.0 μm per side, more preferably 0.005 per side.
~ 0.8 μm is suitable.
【0012】本発明における多層フィルム(C)はかよ
うなガスバリアー性セラミックコートフィルムを層成分
として含む多層フィルムであり、力学的性質、シール
性、耐ピンホールなどの点からポリエチレン、ポリプロ
ピレン、ナイロン、ポリエステルなどのフィルムと適宜
貼り合わされている。The multi-layer film (C) in the present invention is a multi-layer film containing such a gas barrier ceramic coating film as a layer component, and is made of polyethylene, polypropylene, nylon in view of mechanical properties, sealing properties, pinhole resistance and the like. It is appropriately laminated with a film such as polyester.
【0013】なお、多層フィルム(C)の成分としてセ
ラミックコートフィルムの他にエチレンビニルアルコー
ルコポリマーフィルムを層成分として含ませることを妨
げるものでないことは言うまでもない。Needless to say, it does not prevent inclusion of an ethylene vinyl alcohol copolymer film as a layer component in addition to the ceramic coat film as a component of the multilayer film (C).
【0014】次に本発明におけるエチレンビニルアルコ
ールコポリマーフィルムはエチレン含量が、好ましくは
25〜50モル%、より好ましくは27〜45モル%の
エチレンビニルアルコールコポリマーを通常公知の方法
で製膜して得られるものであり、ガス透過性を考慮する
と、好ましくは3〜100μm、より好ましくは5〜7
0μm程度のものが適当である。Next, the ethylene vinyl alcohol copolymer film in the present invention is obtained by forming an ethylene vinyl alcohol copolymer having an ethylene content of preferably 25 to 50 mol%, more preferably 27 to 45 mol% by a generally known method. Considering gas permeability, it is preferably 3 to 100 μm, more preferably 5 to 7 μm.
A diameter of about 0 μm is suitable.
【0015】本発明における多層フィルム(D)はかよ
うなエチレンビニルアルコールコポリマーフィルムを層
成分として含む多層フィルムであり(C)の場合と同様
な理由でポリエチレン、ポリプロピレン、ナイロン、ポ
リエステルなどのフィルムと適宜貼り合わされている。The multi-layer film (D) in the present invention is a multi-layer film containing such an ethylene vinyl alcohol copolymer film as a layer component, and for the same reason as in the case of (C), a film such as polyethylene, polypropylene, nylon or polyester is used. It is pasted appropriately.
【0016】冒頭に記載した如く、本発明での外包材の
フィルムまたはシート(B)は上記(C)と(D)の多
層フィルムから構成されており(C)をバリアー層とす
る部分と(D)をバリアー層とする部分が別々に存在す
ることが特徴である。これによって(C)および(D)
のガスバリアー/ガス透過性が生かされる。(C)と
(D)との比率は、医薬液の種類、医薬液量に対す
る内包材(A)や外包材の表面積、医薬液の運搬・保
存時の雰囲気(温湿度)や保存時間、多層フィルム
(C)および(D)のガスバリアー性/ガス透過性など
によって適宜決められるが、一般的には面積で95:5
〜20:80、より好ましくは90:10〜30:70
位が良い。(D)の割合が多くなると。温湿度の影響を
受けやすく、また内包医薬液中の水分量が問題になって
来るので、(D)の割合は極力低くするのが良い。As described at the beginning, the film or sheet (B) of the outer wrapping material in the present invention is composed of the multilayer film of the above (C) and (D) and has a portion (C) as a barrier layer ( The feature is that the portions having D) as a barrier layer are separately present. This gives (C) and (D)
The gas barrier / gas permeability of is utilized. The ratios of (C) and (D) are the type of medicinal liquid, the surface area of the inner packaging material (A) and the outer packaging material with respect to the amount of the medicinal liquid, the atmosphere (temperature and humidity) during storage and transportation of the medicinal liquid, the storage time, and the number of layers. It is appropriately determined depending on the gas barrier property / gas permeability of the films (C) and (D), but generally the area is 95: 5.
To 20:80, more preferably 90:10 to 30:70.
The rank is good. When the ratio of (D) increases. Since it is easily affected by temperature and humidity and the amount of water in the encapsulated drug solution becomes a problem, the ratio of (D) should be as low as possible.
【0017】なお本発明の趣旨を損なわない範囲で包材
(B)が(C)、(D)以外のフィルム(シート)を含
んでいても良いことは言うまでもない。Needless to say, the packaging material (B) may contain a film (sheet) other than (C) and (D) within a range not impairing the gist of the present invention.
【0018】本発明の医薬液入り容器は通常公知の方法
を適用して製造され得る。まず軟質プラスチック容器
(A)はTダイ法、インフレーション法、ブロー法など
でシートを形成させ、熱シール、部材(医薬液の注入・
排出口、ゴム栓、チューブなど)取り付けなどを適宜行
って製造される。容器のシートの厚さは0.1〜1mm
程度が一般的である。The container containing the pharmaceutical solution of the present invention can be manufactured by applying a generally known method. First, the soft plastic container (A) is formed into a sheet by a T-die method, an inflation method, a blow method, etc., and heat-sealed, a member (injection of a medicinal solution
It is manufactured by appropriately attaching (exhaust port, rubber stopper, tube, etc.). The thickness of the container sheet is 0.1-1 mm
Degree is general.
【0019】多層フィルム(C)と(D)も(A)と同
様の方法やラミネート法を利用して製造される。多層フ
ィルムの厚さは力学的性質、取り扱いの容易さから0.
05〜0.5mm程度が適当である。外包材(B)は、
(C)と(D)とを熱シール法(熱板接着法、インパル
ス法、超音波法、高周波法など)で接合すれば良い。The multilayer films (C) and (D) are also manufactured by using the same method as that of (A) or the laminating method. The thickness of the multilayer film is 0. because of its mechanical properties and ease of handling.
About 0.5 to 0.5 mm is suitable. The outer packaging material (B) is
(C) and (D) may be joined by a heat sealing method (hot plate bonding method, impulse method, ultrasonic method, high frequency method, etc.).
【0020】なお(A)を(B)で包みこむのは(A)
の滅菌前、滅菌後いずれでも差し支えない。It should be noted that wrapping (A) with (B) is (A)
Before sterilization or after sterilization, it does not matter.
【0021】本発明において(A)と(B)との間の雰
囲気は真空(減圧)、窒素など用途・要求によっては
(A)と(B)との間に脱酸素剤をいれても良い。In the present invention, the atmosphere between (A) and (B) may be a vacuum (reduced pressure), nitrogen, etc., and an oxygen scavenger may be added between (A) and (B) depending on the application and requirements. .
【0022】本発明が対象とする医薬液としては前述の
アミノ酸製剤だけではなく、生理食塩水、電解質液、デ
キストラン製剤、マンニトール製剤、糖質製剤などがあ
る。The medicinal liquid targeted by the present invention includes not only the above-mentioned amino acid preparation but also physiological saline, electrolyte solution, dextran preparation, mannitol preparation, sugar preparation and the like.
【0023】[0023]
【実施例】以下実施例によって本発明をさらに具体的に
説明するが、本発明はこれらに何ら限定されるものでは
ない。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
【0024】(実施例1〜3、比較例1,2) (1)容器およびフィルムについて 医薬液およびこれを直接内蔵する容器(A):ヘキセ
ン−1を共重合成分とする密度0.92g/cm2の線
状低密度ポリエチレン製のバッグ(厚さ300μmのシ
ートからなり40×180×130mmの偏平状の形状
で、一方の端部にはゴム栓が装着された高密度ポリエチ
レン樹脂製の硬質の筒状排液ポートが固着されている)
にアミノ酸約8wt/V%を含有する水溶液からなる輸
液剤を500ml内蔵させ、115℃で20分間の高圧
蒸気滅菌を施した。(Examples 1 to 3 and Comparative Examples 1 and 2) (1) Container and Film Container (A) directly containing the medicinal liquid and the same: Density with hexene-1 as a copolymerization component 0.92 g / cm 2 linear low-density polyethylene bag (made of 300 μm-thick sheet, flat shape of 40 × 180 × 130 mm, with rubber plug attached to one end The cylindrical drain port of is fixed)
500 ml of an infusion solution consisting of an aqueous solution containing about 8 wt / V% of amino acid was incorporated into the solution and sterilized under high pressure steam at 115 ° C. for 20 minutes.
【0025】多層フィルム(C):酸化ケイ素膜を蒸
着法により形成させた(蒸着面は片面)、厚さ12μm
のポリエチレンテレフタレートフィルムの蒸着面側に厚
さ15μmのナイロン6フィルムを厚さ50μmの低密度
ポリエチレンフィルムをラミネートして透明な多層フィ
ルム(C)を得た。このフィルム(C)の酸素ガス透過
度と透湿度を表1に示す(MOCONの装置を用い
た)。Multilayer film (C): A silicon oxide film was formed by a vapor deposition method (the vapor deposition surface was one side), and the thickness was 12 μm.
A nylon 6 film having a thickness of 15 μm was laminated on a low density polyethylene film having a thickness of 50 μm on the vapor-deposited surface side of the polyethylene terephthalate film (1) to obtain a transparent multilayer film (C). The oxygen gas permeability and moisture permeability of this film (C) are shown in Table 1 (using a MOCON device).
【0026】多層フィルム(D):厚さ12μmのポ
リエチレンテレフタレートフィルム、厚さ15μmのエ
チレンビニルアルコールコポリマーフィルム(エチレン
含量32モル%)、厚さ12μmのナイロンフィルムお
よび厚さ50μmの低密度ポリエチレンフィルムをこの
順にラミネートして透明な多層フィルム(D)を得た。
このフィルム(D)の酸素ガス透過度と透湿度を表1に
示す。Multilayer film (D): 12 μm thick polyethylene terephthalate film, 15 μm thick ethylene vinyl alcohol copolymer film (ethylene content 32 mol%), 12 μm thick nylon film and 50 μm thick low density polyethylene film. By laminating in this order, a transparent multilayer film (D) was obtained.
Table 1 shows the oxygen gas permeability and moisture permeability of this film (D).
【0027】[0027]
【表1】 [Table 1]
【0028】医薬液入り容器の調整:の医薬液内蔵
容器(A)を滅菌処理後10分以内に多層フィルム
(C)および/または多層フィルム(D)で構成された
外包材に包んでシールした(シール面は低密度ポリエチ
レン側である)。これら外包材の全表面積はそれぞれ7
50cm2である。Preparation of Container Containing Pharmaceutical Solution: The container containing medical solution (A) was wrapped and sealed within 10 minutes after sterilization with an outer packaging material composed of the multilayer film (C) and / or the multilayer film (D). (The sealing surface is the low density polyethylene side). The total surface area of each of these outer packaging materials is 7
It is 50 cm 2 .
【0029】医薬液入り容器の経時変化試験:の医
薬液入り容器5種について、40℃×90%RHの雰囲
気下での放置(12時間)と23℃×90%RHの雰囲
気下での放置(12時間)を20回繰り返した。(合計
20日)。Test of time-dependent change of containers containing medicinal liquid: Five kinds of containers containing medicinal liquid were left in an atmosphere of 40 ° C. × 90% RH (12 hours) and left in an atmosphere of 23 ° C. × 90% RH. (12 hours) was repeated 20 times. (20 days in total).
【0030】(2)実験結果(表2参照) 表2に示した通り上記の経時変化試験で得られたサン
プルの観察結果は、フィルム(C)単独(比較例1)お
よびフィルム(D)単独(比較例2)のそれぞれの問題
である水滴発生、内容液の黄変が(C)と(D)との併
用で解消されることがわかった。(2) Experimental results (see Table 2) As shown in Table 2, the observation results of the samples obtained in the above-described aging test are as follows: Film (C) alone (Comparative Example 1) and Film (D) alone. It was found that the water droplet generation and the yellowing of the content liquid, which are the respective problems of (Comparative Example 2), were eliminated by the combined use of (C) and (D).
【0031】[0031]
【0032】[0032]
【表2】 [Table 2]
【0033】[0033]
【0034】[0034]
【発明の効果】以上記述した如く、本発明の医薬液入り
容器はセラミックコートフィルムとエチレンビニルアル
コールコポリマーフィルムの特性を巧みに生かして生じ
たものであり、医薬液の安定保存に大きな効果を発揮
し、廃棄処理時の問題も少ない。またその構成は汎用性
に富み、その工業的価値は高いものがある。Industrial Applicability As described above, the container of the present invention containing a medicinal solution is produced by skillfully utilizing the characteristics of the ceramic coat film and the ethylene vinyl alcohol copolymer film, and exerts a great effect on the stable storage of the medicinal solution. However, there are few problems during disposal. In addition, the structure is versatile and has high industrial value.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 B65D 75/38 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI technical display location B65D 75/38
Claims (1)
ック容器(A)および(A)を内包する密封されたフィ
ルムまたはシート(B)からなる容器であって、(B)
がガスバリアー性セラミックコートフィルムを層として
含む多層フィルム(C)の部分とエチレンビニルアルコ
ールコポリマーフィルムを層として含む多層フィルム
(D)の部分とで構成されていることを特徴とする医薬
液入り容器。1. A container comprising a sealed soft plastic container (A) containing a medicinal solution and a sealed film or sheet (B) containing (A), which comprises (B)
Is composed of a multi-layer film (C) part containing a gas barrier ceramic coat film as a layer and a multi-layer film (D) part containing an ethylene vinyl alcohol copolymer film as a layer. .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5250584A JPH07100185A (en) | 1993-10-06 | 1993-10-06 | Container for medical liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5250584A JPH07100185A (en) | 1993-10-06 | 1993-10-06 | Container for medical liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07100185A true JPH07100185A (en) | 1995-04-18 |
Family
ID=17210067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5250584A Pending JPH07100185A (en) | 1993-10-06 | 1993-10-06 | Container for medical liquid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07100185A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002527360A (en) * | 1998-10-14 | 2002-08-27 | バイオピュア コーポレーション | How to save hemoglobin blood substitute |
| JP2008259830A (en) * | 2001-03-27 | 2008-10-30 | Nipro Corp | Albumin housing plastic container |
-
1993
- 1993-10-06 JP JP5250584A patent/JPH07100185A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002527360A (en) * | 1998-10-14 | 2002-08-27 | バイオピュア コーポレーション | How to save hemoglobin blood substitute |
| JP2008259830A (en) * | 2001-03-27 | 2008-10-30 | Nipro Corp | Albumin housing plastic container |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4654240A (en) | Laminate film for flexible containers | |
| EP1520574B1 (en) | Flexible medical container packaging | |
| EP0619178B1 (en) | Process for producing multilayered film materials | |
| US5763028A (en) | Doubly-packaged easily oxidizable article | |
| JP5012585B2 (en) | Albumin-containing plastic container | |
| JPS5984719A (en) | Manufacture of plastic vessel containing chemical which do not deteriorate for prolonged term | |
| JPH11128315A (en) | Medical container | |
| KR100260976B1 (en) | Split package of oral adsorbent and method for preparing same | |
| RU2381103C2 (en) | Container for liquid pharmaceutical compositions with high moistureproof properties | |
| JP2022167997A (en) | Plastic container, and package comprising exterior body | |
| JP4254117B2 (en) | Albumin solution-containing plastic container | |
| JP2906487B2 (en) | Medical article transparent package | |
| JPH07100185A (en) | Container for medical liquid | |
| JPH09308682A (en) | Plastic film for medical liquid containers | |
| JPS6311160A (en) | Drug liquid plastic container preventing deterioration of drug liquid by oxygen and its production | |
| JP2825898B2 (en) | Laminated film for packaging | |
| JP2607422B2 (en) | Packaging for adsorbent for internal use and method for producing the same | |
| JPH0549673A (en) | Container for liquid drug | |
| JPH031021B2 (en) | ||
| JPH0532282Y2 (en) | ||
| JP2837434B2 (en) | Infusion bag | |
| JPH1156970A (en) | Medical container | |
| JPH07231929A (en) | Medical fluid-containing container | |
| JPH05309124A (en) | Medicinal liquid container envelope | |
| JPS6382665A (en) | Medical plastic container |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |